HEMO Invest ApS: Financial statements 2025
CVR: 38403125
Source: annual report 2025, Danish Business Authority
01/01/2025 – 31/12/2025
HEMO Invest ApS (CVR 38403125) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -31,106 and a net result of DKK 527,412 compared with DKK 2,192,878 the year before. Equity in the 2025 report amounted to DKK 29,897,046. The solvency ratio was 99.7%. The company had 1 employee in the financial year.
- Gross Profit
- DKK -31,106
- Profit/Loss
- DKK 527,412
- Equity
- DKK 29,897,046
- Total Assets
- DKK 29,975,197
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2025 | - | -31K | 527K | 29.9M | 1 |
| 2024 | - | -35K | 2.2M | 29.9M | 1 |
| 2023 | - | -62K | 1.5M | 28.3M | 1 |
| 2022 | - | -29K | -3.1M | 27.6M | - |
| 2021 | - | -55K | 17.2M | 30.8M | - |
Official annual report
How creditworthy is HEMO Invest ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2025
HEMO Invest ApS has published its annual report for 2024. Gross profit came to DKK -34,923, and the net result was DKK 2,192,878.
About HEMO Invest ApS
HEMO Invest ApS is a Danish company of the type Anpartsselskab based in Juelsminde, founded in 2016. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Henrik Mortensen. The company is owned by Henrik Mortensen. The company has 1 employee (2026). In 2025, the company reported a gross profit of DKK -31,106 and a net result of DKK 527,412 compared with DKK 2,192,878 the year before. Equity in the 2025 report amounted to DKK 29,897,046.
